Month: August 2021

news_6

Bio-Thera Solutions and Hikma Pharmaceuticals Announce Exclusive Commercialization and License Agreement for BAT2206 in the US, a Proposed Biosimilar Referencing Stelara® (ustekinumab)

GUANGZHOU, China & LONDON--(BUSINESS WIRE)--#Hikma--Bio-Thera Solutions, Ltd. (688177.SH) and Hikma Pharmaceuticals PLC (LSE: HIK) today announced that they have entered...

Fobi-AI-Inc-

Fobi Launches CheckVax™ Digital Proof of Vaccination Service To Provide Global Venues And Businesses With Solution To Immediately Comply With Government Or Self Imposed Vaccine Mandates